60 related articles for article (PubMed ID: 30041179)
1. Upregulation of MIAT Regulates LOXL2 Expression by Competitively Binding MiR-29c in Clear Cell Renal Cell Carcinoma.
Qu Y; Xiao H; Xiao W; Xiong Z; Hu W; Gao Y; Ru Z; Wang C; Bao L; Wang K; Ruan H; Song Z; Chen K; Zhang X; Yang H
Cell Physiol Biochem; 2018; 48(3):1075-1087. PubMed ID: 30041179
[TBL] [Abstract][Full Text] [Related]
2. lncRNA MIR4435-2HG promoted clear cell renal cell carcinoma malignant progression via miR-513a-5p/KLF6 axis.
Zhu K; Miao C; Tian Y; Qin Z; Xue J; Xia J; Zhu S; Xu A; Yang J; Wang Z
J Cell Mol Med; 2020 Sep; 24(17):10013-10026. PubMed ID: 33460239
[TBL] [Abstract][Full Text] [Related]
3. LncRNA MAGI2-AS3 inhibites tumor progression by up-regulating STAM via interacting with miR-142-3p in clear cell renal cell carcinoma.
Yang R; Chen Z; Ao S; Liang L; Chen Z; Duan X; Zeng G; Deng T
Cell Signal; 2024 Jan; 113():110954. PubMed ID: 38084836
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis of N6-Methylandenosine-Related lncRNAs in Clear Cell Renal Cell Carcinoma: A Correlation With Prognosis, Tumor Progression, and Therapeutic Response.
Meng C; Li J; Wang X; Ying Y; Li Z; Wang A; Li X
Cancer Invest; 2024 Apr; 42(4):278-296. PubMed ID: 38644691
[TBL] [Abstract][Full Text] [Related]
5. miRNA-27b-3p/TPX2 Axis Regulates Clear Cell Renal Cell Carcinoma Cell Proliferation, Invasion and Migration.
Liu N; Jiang Y; Chen S; Pan F; Tang Y; Tan X
Crit Rev Eukaryot Gene Expr; 2024; 34(1):27-39. PubMed ID: 37824390
[TBL] [Abstract][Full Text] [Related]
6. lncRNA MIAT promotes luminal B breast cancer cell proliferation, migration, and invasion in vitro.
Mi J; Zhang H; Jiang X; Yi Y; Cao W; Song C; Yuan C
J Appl Genet; 2024 May; 65(2):309-319. PubMed ID: 37987972
[TBL] [Abstract][Full Text] [Related]
7. MiR-1294 acts as a tumor suppressor in clear cell renal cell carcinoma through targeting HOXA6.
Pan W; Pang LJ; Cai HL; Wu Y; Zhang W; Fang JC
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3719-3725. PubMed ID: 31114997
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Analysis of Regulatory Network for LINC00472 in Clear Cell Renal Cell Carcinoma.
Gao S; Wang Z
J Healthc Eng; 2021; 2021():3533608. PubMed ID: 34221297
[TBL] [Abstract][Full Text] [Related]
9. LncRNA IPW inhibits growth of ductal carcinoma in situ by downregulating ID2 through miR-29c.
Deshpande RP; Sharma S; Liu Y; Pandey PR; Pei X; Wu K; Wu SY; Tyagi A; Zhao D; Mo YY; Watabe K
Breast Cancer Res; 2022 Jan; 24(1):6. PubMed ID: 35078502
[TBL] [Abstract][Full Text] [Related]
10. PPARγ is dispensable for clear cell renal cell carcinoma progression.
Sanchez DJ; Steger DJ; Skuli N; Bansal A; Simon MC
Mol Metab; 2018 Aug; 14():139-149. PubMed ID: 29866440
[TBL] [Abstract][Full Text] [Related]
11. Targeting the long non-coding RNA MIAT for the treatment of fibroids in an animal model.
Chuang TD; Ton N; Manrique N; Rysling S; Khorram O
Clin Sci (Lond); 2024 Jun; 138(12):699-709. PubMed ID: 38817011
[TBL] [Abstract][Full Text] [Related]
12. The m
He Y; Chen Y; Li Z; Wu C
J Cancer Res Clin Oncol; 2024 Jan; 150(2):30. PubMed ID: 38270643
[TBL] [Abstract][Full Text] [Related]
13. LINC00493-encoded microprotein SMIM26 exerts anti-metastatic activity in renal cell carcinoma.
Meng K; Lu S; Li YY; Hu LL; Zhang J; Cao Y; Wang Y; Zhang CZ; He QY
EMBO Rep; 2023 Jun; 24(6):e56282. PubMed ID: 37009826
[TBL] [Abstract][Full Text] [Related]
14. Lysine methyltransferase 5C increases the proliferation and metastatic abilities of clear cell renal cell carcinoma via aerobic glycolysis.
Zeng B; Wan R; Chang K; Li J; Zhang X; Shi G; Ye D; Xu F
Int J Oncol; 2024 Apr; 64(4):. PubMed ID: 38426605
[TBL] [Abstract][Full Text] [Related]
15. Role of LncRNA MIAT in Diabetic Complications.
Wang L; Wang H; Luo Y; Wu W; Gui Y; Zhao J; Xiong R; Li X; Yuan D; Yuan C
Curr Med Chem; 2024; 31(13):1716-1725. PubMed ID: 37711129
[TBL] [Abstract][Full Text] [Related]
16. NNT-induced tumor cell "slimming" reverses the pro-carcinogenesis effect of HIF2a in tumors.
Xiong Z; Xiong W; Xiao W; Yuan C; Shi J; Huang Y; Wang C; Meng X; Chen Z; Yang H; Chen K; Zhang X
Clin Transl Med; 2021 Jan; 11(1):e264. PubMed ID: 33463050
[TBL] [Abstract][Full Text] [Related]
17. PDZK1 confers sensitivity to sunitinib in clear cell renal cell carcinoma by suppressing the PDGFR-β pathway.
Wang H; Zhang L; Liu H; Yang Y; Lu W; Cao X; Yang X; Qin Q; Song R; Feng D; Wang S; Bai T; He J
Br J Cancer; 2024 May; ():. PubMed ID: 38822145
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of NQO1-activated prodrugs of podophyllotoxin as antitumor agents.
Qu Y; Zhang C; Ma X; Gao Y; Liu J; Wu L
Bioorg Med Chem; 2020 Dec; 28(24):115821. PubMed ID: 33091789
[TBL] [Abstract][Full Text] [Related]
19. Selection of M7G-related lncRNAs in kidney renal clear cell carcinoma and their putative diagnostic and prognostic role.
Zhong S; Chen S; Lin H; Luo Y; He J
BMC Urol; 2023 Nov; 23(1):186. PubMed ID: 37968670
[TBL] [Abstract][Full Text] [Related]
20. LOXL2 in Cancer: A Two-Decade Perspective.
Cano A; Eraso P; Mazón MJ; Portillo F
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
